BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 10616185)

  • 1. Regulation of biologicals in the European Union.
    Vicari G
    Dev Biol Stand; 1999; 100():145-8. PubMed ID: 10616185
    [No Abstract]   [Full Text] [Related]  

  • 2. Regulatory framework of immunologicals in the European Union.
    Sauer F
    Biologicals; 1994 Dec; 22(4):307-11. PubMed ID: 7779353
    [No Abstract]   [Full Text] [Related]  

  • 3. Regulation of biologicals in China.
    Zhou H
    Dev Biol Stand; 1999; 100():155-8. PubMed ID: 10616187
    [No Abstract]   [Full Text] [Related]  

  • 4. Transposition of the Blood Directive into national law--the perspective of Portugal.
    Gonçalves MH; Muon MC; Gonçalves Jd
    Transfus Clin Biol; 2005 Feb; 12(1):18-20. PubMed ID: 15814287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of the European Union enlargement on health professionals and health care systems.
    Avgerinos ED; Koupidis SA; Filippou DK
    Health Policy; 2004 Sep; 69(3):403-8. PubMed ID: 15276318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The regulation of medicinal products derived from human blood or plasma in the European Community.
    Brunko P
    Dev Biol Stand; 1993; 81():269-71. PubMed ID: 8174813
    [No Abstract]   [Full Text] [Related]  

  • 7. Current regulatory and legal considerations for follow-on biologics.
    Kingham RF; Lietzan E
    Clin Pharmacol Ther; 2008 Nov; 84(5):633-5. PubMed ID: 18716615
    [No Abstract]   [Full Text] [Related]  

  • 8. The EEC and the regulation of blood derivatives.
    Horaud F
    Dev Biol Stand; 1993; 81():273-6. PubMed ID: 8174814
    [No Abstract]   [Full Text] [Related]  

  • 9. International Conference on Harmonisation; guidance on specifications: test procedures and acceptance criteria for biotechnological/biological products. Notice. Food and Drug Administration, HHS.
    Fed Regist; 1999 Aug; 64(159):44928-35. PubMed ID: 12356094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. International Conference on Harmonisation; guidance on quality of biotechnological/biological products: derivation and characterization of cell substrates used for production of biotechnological/biological products; availability. Notice. Food and Drug Administration, HHS.
    Fed Regist; 1998 Sep; 63(182):50244-9. PubMed ID: 12269373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Health policy and European law: closing the gaps.
    McKee M; Mossialos E
    Public Health; 2006 Oct; 120 Suppl():16-21; discussion 21-2. PubMed ID: 16979200
    [No Abstract]   [Full Text] [Related]  

  • 12. The procedure for marketing authorization for veterinary medicinal products derived from biotechnology in the European community.
    Brunko P
    Dev Biol Stand; 1992; 79():11-5. PubMed ID: 1286745
    [No Abstract]   [Full Text] [Related]  

  • 13. ["The mental health of the population--better deployment of a strategy for mental health in the European Union": The Commission of the European Community].
    Hohagen F;
    Nervenarzt; 2006 Jun; 77(6):745-8. PubMed ID: 16855850
    [No Abstract]   [Full Text] [Related]  

  • 14. The shape of European business in 2003.
    Wagner M
    Med Device Technol; 2002 Dec; 13(10):8-10. PubMed ID: 12575520
    [No Abstract]   [Full Text] [Related]  

  • 15. Nursing and the EU Accession Process.
    Keighley T
    Int Nurs Rev; 2006 Jun; 53(2):81-2. PubMed ID: 16650020
    [No Abstract]   [Full Text] [Related]  

  • 16. European Regulatory guidance on virus safety of recombinant proteins, monoclonal antibodies and plasma derived medicinal products.
    Celis P; Silvester G
    Dev Biol (Basel); 2004; 118():3-10. PubMed ID: 15645667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ASTM lights the way for tissue engineered medical products standards: jump start for combination medical products that restore biological function of human tissues.
    Picciolo GL; Stocum DL
    Stand News; 2001 Jan; 29(1):30-5. PubMed ID: 11833591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety aspects of blood transfusion and European legislation.
    Koistinen JL
    Hematol J; 2004; 5 Suppl 3():S83-6. PubMed ID: 15190284
    [No Abstract]   [Full Text] [Related]  

  • 19. Challenges for biological standardization and control in the 21st century.
    Zoon KC
    Dev Biol Stand; 1999; 100():95-9. PubMed ID: 10616180
    [No Abstract]   [Full Text] [Related]  

  • 20. An overview of European Union tobacco control legislation.
    Godfrey F
    Cent Eur J Public Health; 2000 May; 8(2):128-31. PubMed ID: 10857053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.